Works matching IS 13524585 AND DT 2019 AND VI 25 AND IP 14

Results: 17

Severe B cell–mediated disease activation despite two cycles of alemtuzumab in a patient with multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1942, doi. 10.1177/1352458518810261

By:

Hyun, Jae-Won;
Kim, Yeseul;
Kim, Gayoung;
Kim, Su-Hyun;
Kim, Ho Jin

Publication type:

Article

Regulatory B cells: The key to post-alemtuzumab rebound phenomena in multiple sclerosis?

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1945, doi. 10.1177/1352458518810258

By:

Hardy, Todd A

Publication type:

Article

Month-of-birth-effect in multiple sclerosis in Austria.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1870, doi. 10.1177/1352458518810924

By:

Walleczek, Nina-Katharina;
Frommlet, Florian;
Bsteh, Gabriel;
Eggers, Christian;
Rauschka, Helmut;
Koppi, Stefan;
Assar, Hamid;
Ehling, Rainer;
Birkl, Christoph;
Salhofer-Polanyi, Sabine;
Baumgartner, Anna;
Blechinger, Stephan;
Buchinger, Dominic;
Sellner, Johann;
Kraus, Jörg;
Moser, Hermann;
Mayr, Markus;
Guger, Michael;
Rathmaier, Sandra;
Raber, Bettina

Publication type:

Article

Histopathological correlation of diffusion basis spectrum imaging metrics of a biopsy-proven inflammatory demyelinating brain lesion: A brief report.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1937, doi. 10.1177/1352458518786072

By:

Shirani, Afsaneh;
Sun, Peng;
Schmidt, Robert E;
Trinkaus, Kathryn;
Naismith, Robert T;
Song, Sheng-Kwei;
Cross, Anne H

Publication type:

Article

Resting-state MEG measurement of functional activation as a biomarker for cognitive decline in MS.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1896, doi. 10.1177/1352458518810260

By:

Schoonhoven, Deborah N;
Fraschini, Matteo;
Tewarie, Prejaas;
Uitdehaag, Bernard MJ;
Eijlers, Anand JC;
Geurts, Jeroen JG;
Hillebrand, Arjan;
Schoonheim, Menno M;
Stam, Cornelis J;
Strijbis, Eva MM

Publication type:

Article

Introducing the Barancik Prize lecture series.

Published in:

2019

By:

Coetzee, Timothy;
Bebo, Bruce

Publication type:

Editorial

An asymptomatic new lesion on MRI is a relapse and should be treated accordingly – Commentary.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1845, doi. 10.1177/1352458519885110

By:

Arrambide, Georgina;
Tintore, Mar

Publication type:

Article

Remyelination and ageing: Reversing the ravages of time.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1835, doi. 10.1177/1352458519884006

By:

Neumann, Bjoern;
Segel, Michael;
Chalut, Kevin J;
Franklin, Robin JM

Publication type:

Article

Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1848, doi. 10.1177/1352458519879094

By:

Wojcik, Curtis M;
Beier, Meghan;
Costello, Kathleen;
DeLuca, John;
Feinstein, Anthony;
Goverover, Yael;
Gudesblatt, Mark;
Jaworski III, Michael;
Kalb, Rosalind;
Kostich, Lori;
LaRocca, Nicholas G;
Rodgers, Jonathan D;
Benedict, Ralph HB

Publication type:

Article

An asymptomatic new lesion on MRI is a relapse and should be treated accordingly – Yes.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1842, doi. 10.1177/1352458519855723

By:

Rojas, Juan Ignacio;
Patrucco, Liliana;
Cristiano, Edgardo

Publication type:

Article

The MSBase registry: Informing clinical practice.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1828, doi. 10.1177/1352458519848965

By:

Kalincik, Tomas;
Butzkueven, Helmut

Publication type:

Article

An asymptomatic new lesion on MRI is a relapse and should be treated accordingly – No.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1843, doi. 10.1177/1352458519845111

By:

Chard, Declan T;
Trip, S Anand

Publication type:

Article

Optic nerve double inversion recovery hypersignal in patients with clinically isolated syndrome is associated with asymptomatic gadolinium-enhanced lesion.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1888, doi. 10.1177/1352458518815797

By:

London, Frédéric;
Zéphir, Hélène;
Hadhoum, Nawal;
Lannoy, Julien;
Vermersch, Patrick;
Pruvo, Jean-Pierre;
Hodel, Jérôme;
Leclerc, Xavier;
Outteryck, Olivier

Publication type:

Article

Spinal cord and infratentorial lesions in radiologically isolated syndrome are associated with decreased retinal ganglion cell/inner plexiform layer thickness.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1878, doi. 10.1177/1352458518815597

By:

Filippatou, Angeliki;
Shoemaker, Thomas;
Esch, Megan;
Qutab, Madiha;
Gonzalez-Caldito, Natalia;
Prince, Jerry L;
Mowry, Ellen M;
Calabresi, Peter A;
Saidha, Shiv;
Sotirchos, Elias S

Publication type:

Article

Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1926, doi. 10.1177/1352458518815596

By:

Chien, Claudia;
Scheel, Michael;
Schmitz-Hübsch, Tanja;
Borisow, Nadja;
Ruprecht, Klemens;
Bellmann-Strobl, Judith;
Paul, Friedemann;
Brandt, Alexander U

Publication type:

Article

Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1915, doi. 10.1177/1352458518814117

By:

Elliott, Colm;
Wolinsky, Jerry S;
Hauser, Stephen L;
Kappos, Ludwig;
Barkhof, Frederik;
Bernasconi, Corrado;
Wei, Wei;
Belachew, Shibeshih;
Arnold, Douglas L

Publication type:

Article

Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1907, doi. 10.1177/1352458518811597

By:

Oliveira, Luana Michelli;
Apóstolos-Pereira, Samira Luisa;
Pitombeira, Milena Sales;
Bruel Torretta, Pedro Henrique;
Callegaro, Dagoberto;
Sato, Douglas Kazutoshi

Publication type:

Article